Dennis H Robinson

US Patent:

20030212130, Nov 13, 2003

Filed:

Feb 12, 2003

Appl. No.:

10/365666

Inventors:

Donald Miller - Omaha NE, US
Samuel Augustine - Omaha NE, US
Jon Wagner - Omaha NE, US
Thomas McDonald - Omaha NE, US
Dennis Robinson - Omaha NE, US

International Classification:

A61K031/22
A61K031/198

US Classification:

514/551000, 514/565000

Abstract:

The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.

US Patent:

20090137669, May 28, 2009

Filed:

Dec 13, 2007

Appl. No.:

11/955681

Inventors:

Donald W. Miller - Winnepeg, CA
Samuel C. Augustine - Omaha NE, US
Jon C. Wagner - Omaha NE, US
Thomas L. McDonald - Omaha NE, US
Dennis H. Robinson - Omaha NE, US

International Classification:

A61K 31/221
C07C 229/10
A61P 29/00

US Classification:

514551, 560168

Abstract:

The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.

US Patent:

20110224174, Sep 15, 2011

Filed:

Mar 12, 2010

Appl. No.:

12/723003

Inventors:

Donald W. Miller - Winnipeg, CA
Samuel C. Augustine - Omaha NE, US
Jon C. Wagner - Omaha NE, US
Thomas L. McDonald - Omaha NE, US
Dennis H. Robinson - Omaha NE, US

International Classification:

A61K 31/66
A61K 31/22
A61P 29/00

US Classification:

514115, 514551

Abstract:

The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.

US Patent:

52949940, Mar 15, 1994

Filed:

Apr 6, 1992

Appl. No.:

7/863612

Inventors:

Dennis C. Robinson - Marlboro MA
Jeffrey P. Copeland - Holden MA
Ricardo L. Fernandez - Beverly MA
Steve D. Venditti - Newton MA
Daniel J. J. Velasco - Hudson MA

Assignee:

Digital Equipment Corporation - Maynard MA

International Classification:

H04N 530
H05K 500
H05K 900
H01J 152

US Classification:

348825

Abstract:

An computer assembly having an integral video display and processor subsystem in a single enclosure is described. The assembly contains an electrically conductive safety wall inside the enclosure which separates the interior of the enclosure into a high-voltage region where the video display components are mounted, and a low-voltage region where the processor subsystem is mounted. The enclosure has a removable rear cover which allows access to the processor subsystem for upgrading memory. An electrically conductive liner is attached to the rear cover for EMI shielding of the low-voltage region.

US Patent:

52275825, Jul 13, 1993

Filed:

Apr 6, 1992

Appl. No.:

7/864114

Inventors:

Daniel J. J. Velasco - Hudson MA
Dennis C. Robinson - Marlboro MA
Jeffrey P. Copeland - Holden MA
Ricardo L. Fernandez - Beverly MA

Assignee:

Digital Equipment Corporation - Maynard MA

International Classification:

H05K 900

US Classification:

174 35R

Abstract:

The disclosed invention relates to a video display system having a device for shielding electromagnetic radiation emitted from electrical wires which connect a video amplifier to a cathode ray tube. The device uses inexpensive unshielded wires which are recessed within a conductive shielding enclosure. The wires are connected to the cathode ray tube by a socket which is positioned at an access opening in the shielding enclosure. The invention further relates to a device for mounting a shielding enclosure to a base using tabs on the enclosure which are captured in an interference fit between the surface of the base and brackets coupled to the base.

US Patent:

51928930, Mar 9, 1993

Filed:

Apr 6, 1992

Appl. No.:

7/863615

Inventors:

Daniel J. J. Velasco - Hudson MA
Dennis C. Robinson - Marlboro MA
Jeffrey P. Copeland - Holden MA
Ricardo L. Fernandez - Beverly MA

Assignee:

Digital Equipment Corporation - Maynard MA

International Classification:

H01J 152
H01J 502

US Classification:

315 85

Abstract:

The disclosed invention relates to a video display system having a device for shielding electromagnetic radiation emitted from electrical wires which connect a video amplifier to a cathode ray tube. The device uses inexpensive unshielded wires which are recessed within a conductive shielding enclosure. The wires are connected to the cathode ray tube by a socket which is positioned at an access opening in the shielding enclosure. The invention further relates to a device for mounting a shielding enclosure to a base using tabs on the enclosure which are captured in an interference fit between the surface of the base and brackets coupled to the base.

US Patent:

57284032, Mar 17, 1998

Filed:

Oct 5, 1994

Appl. No.:

8/317695

Inventors:

John W. Mauger - Salt Lake City UT
Dennis H. Robinson - Omaha NE

Assignee:

The Board of Regents of the University of Nebraska - Lincoln NE

International Classification:

A61K 914

US Classification:

424486

Abstract:

A pharmaceutical coating for taste masking oral medications is described which includes a unique combination of triglycerides and a polymer. The triglyceride mixture melts at body temperature and the copolymer causes the coating to dissolve upon reaching the acidic environment of the stomach.

US Patent:

20180153844, Jun 7, 2018

Filed:

Dec 4, 2017

Appl. No.:

15/830150

Inventors:

- Lincoln NE, US
Samuel C. Augustine - Omaha NE, US
Jon C. Wagner - Omaha NE, US
Thomas L. McDonald - Omaha NE, US
Dennis H. Robinson - Omaha NE, US

Assignee:

Board of Regents of the University of Nebraska - Lincoln NE

International Classification:

A61K 31/22
A61K 31/66

Abstract:

The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.